11/21/2011 - 2:25pm

Perrigo on Monday named Christopher Roop to the post of VP corporate development.

11/21/2011 - 2:07pm

Drug maker Gilead Sciences will acquire Pharmasset for $11 billion, or $137 per share, Gilead said Monday.

11/21/2011 - 12:59pm

After being unanimously recommended for approval by a Food and Drug Administration panel, the FDA has approved an eye disorder treatment created by Regeneron Pharmaceuticals.

11/18/2011 - 2:12pm

Citi Investment Research & Analysis is projecting that the peak of flu season may occur beyond last season's peak of January/February, a factor that may place a negative drag on retail same-store sales results over first quarter 2012.

11/18/2011 - 11:48am

A drug widely used to treat breast cancer is not safe or effective, the Food and Drug Administration said Friday.

11/17/2011 - 3:53pm

Bristol-Myers Squibb and AstraZeneca presented an analysis Wednesday of 14 clinical trials at the American Heart Association's Scientific Sessions in Orlando, Fla., the companies said.

11/17/2011 - 3:45pm

GlaxoSmithKline announced the results from the first of eight phase-3 clinical trials that examined the efficacy of albiglutide in the treatment of Type 2 diabetes.

11/17/2011 - 11:12am

Drug maker Eli Lilly is donating more than $4 million to the Infectious Disease Research Institute, the company said Thursday.

11/16/2011 - 4:36pm

When its blockbuster cholesterol drug Lipitor loses patent protection this month, Pfizer is hoping that pharmacy benefit managers will not dispense a generic version of the drug to its customers, according to published reports.